Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2025-12-25 @ 3:26 AM
NCT ID:
NCT03061305
Eligibility Criteria:
Inclusion Criteria:
* Subjects must be ≥ 18 years of age.
* Subjects must have histologically documented solid tumors (including lymphoma and multiple myeloma).
* Specific criteria for individual tumor types are as follows:
1. Participants with gliomas are eligible at any stage of disease
2. Participants with pancreatic carcinoma are eligible at any stage of disease
3. Participants with rare tumors (i.e. cancer started in an unusual place in the body, it is unusual type and requires special treatment) are eligible at stages II-IV.
4. Participants with other tumor types must have recurrent, relapsed, refractory, metastatic, or advanced stages III or IV cancer.
5. Participants with other tumor types must have recurrent, relapsed, refractory, metastatic, or advanced stages III or IV cancer.
* Must have an adequate formalin-fixed paraffin-embedded tumor specimen for genomic sequencing.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03061305
Study Brief:
Protocol Section:
NCT03061305